8-K Spyre Therapeutics, Inc. 2026-09-08: filing_items
| Value | {"items": {"7.01": "Regulation FD Disclosure", "8.01": "Other Events", "9.01": "Financial Statements and Exhibits"}, "value": "7.01,8.01,9.01"} |
|---|---|
| Period | (as of 2026-09-08) |
| Status | current |
| Entity | 8-K Spyre Therapeutics, Inc. 2026-09-08 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1636282/000163628226000113/0001636282-26-000113-in
Retrieved: 2026-09-08T14:17:34.842910+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/bcc423ff-940e-45da-b818-df1ed718b9eb
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1636282/000163628226000113/0001636282-26-000113-in
Retrieved: 2026-09-08T14:17:34.842910+02:00
Raw response sha256:
d6d05d9478ed73e2ce856581fb84e8cc…Cite as: FACTANKER, https://factanker.com/fact/bcc423ff-940e-45da-b818-df1ed718b9eb
History
- no predecessors — first report